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Randomised controlled trial of atraumatic versus standard
needles for diagnostic lumbar puncture
S Rachel Thomas, D R S Jamieson, Keith W Muir
Abstract
Objective To compare the ease of use of atraumatic
needles with standard needles for diagnostic lumbar
puncture and the incidence of headache after their
use.
Design Double blind, randomised controlled trial.
Setting Investigation ward of a neurology unit in a
university hospital.
Participants 116 patients requiring elective diagnostic
lumbar puncture.
Interventions Standardised protocol for lumbar
puncture with 20 gauge atraumatic or standard
needles.
Outcome measures The primary end point was
intention to treat analysis of incidence of moderate to
severe headache, assessed at one week by telephone
interview. Secondary end points were incidence of
headache at one week analysed by needle type, ease
of use by operator according to a visual analogue
scale, incidence of backache, and failure rate of
puncture.
Results Valid outcome data were available for 97 of
101 patients randomised. Baseline characteristics were
matched except for higher body mass index in the
standard needle group. By an intention to treat
analysis the absolute risk of moderate to severe
headache with atraumatic needles was reduced by
26% (95% confidence interval 6% to 45%) compared
with standard needles, but there was a
non›significantly greater absolute risk of multiple
attempts at lumbar puncture (14%, − 4% to 32%).
Higher body mass index was associated with an
increased failure rate with atraumatic needles, but the
reduced incidence of headache was maintained. The
need for medical interventions was reduced by 20%
(1% to 40%).
Conclusions Atraumatic needles significantly reduced
the incidence of moderate to severe headache and the
need for medical interventions after diagnostic
lumbar punctures, but they were associated with a
higher failure rate than standard needles.
Introduction
Headache due to a reduced volume of cerebrospinal
fluid and reduced pressure complicates a substantial
proportion of lumbar punctures.1–3 In the 1920s
Greene hypothesised that complications could be
reduced by using a smaller, tapered needle with a blunt
tip, which would separate rather than cut dural fibres
and thus reduce fluid leakage.4 5 Atraumatic (“blunt”)
needles have been in clinical use since the 1950s,
principally in anaesthetic practice, where there is
substantial evidence of a reduced incidence of
headache and other neurological complications after
their use.6
Spinal anaesthesia and myelography differ from
diagnostic lumbar puncture because smaller gauge
needles are used, smaller volumes of cerebrospinal
fluid are removed, and other fluids can be introduced.
The incidence of headache after spinal anaesthesia is
typically half that after diagnostic lumbar puncture.2 6
Despite evidence that relevant physical characteristics
of atraumatic needles, such as flow rates, are compara›
ble to those of standard needles,6 there are limited
data on their benefit in diagnostic lumbar puncture.
Also, there is a perception that atraumatic needles are
more difficult to use than standard needles. Previous
studies of diagnostic lumbar puncture have potentially
been confounded by comparing different needle
gauges, failing to define the operators’ previous
experience or the length of follow up, and not
addressing technical difficulties.7–9 The Cochrane Col›
laboration has identified only two methodologically
adequate studies of atraumatic needles for diagnostic
lumbar puncture (C Sudlow, personal communica›
tion). We aimed to compare the incidence of headache
with atraumatic and standard needles and to evaluate
technical difficulties.
Participants and methods
Participants
A local pilot study established the feasibility of training
medical staff on rotation in the use of atraumatic
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needles. We considered as eligible for our study all
patients attending the investigation ward of a regional
neurology unit for elective diagnostic lumbar puncture
between September 1998 and February 1999. We
excluded patients with a history of chronic headache
requiring analgesics and those with known or
suspected idiopathic intracranial hypertension or
other causes of an increased cerebrospinal fluid
pressure. We did not specifically exclude patients if they
had had previous lumbar puncture or spinal surgery or
if other potential confounding factors were present.
Patients received standard information about the pro›
cedure and complications. After consenting, the
patients were randomised to lumbar puncture with
either a 20 gauge atraumatic needle (Sprotte or
Pajunk) or a standard needle (Quincke) (fig 1).
Randomisation was by a computer generated code
stored in opaque envelopes that were serially
numbered and sealed.
Interventions
Seven senior house officers performed the lumbar
punctures over the study period. Each was attached to
the neurology department for three to six months.
Before the study, they received standard training in
lumbar puncture techniques, including the manufac›
turer’s video guidelines on the use of atraumatic
needles. For at least one month they each performed
lumbar punctures with both types of needle. All proce›
dures were performed with the patient in the left lateral
position, and 2% lignocaine was used as local
anaesthetic. The orientation of the needle bevel during
insertion was not stipulated. After withdrawal of
cerebrospinal fluid, the needle stylet was reinserted
routinely before the needle was withdrawn. Operators
were allowed four attempts with the initially allocated
needle type, with a maximum of two attempts at any
one level. If these were unsuccessful, the operator was
allowed two attempts with the alternative needle type
before involving a senior colleague or radiological
guidance (see figure on BMJ ’s website). The use of an
introducer for the atraumatic needles was left to the
operator’s discretion. All patients rested in bed for at
least four hours after the procedure, and fluid intake
was encouraged.
The patients’ age, sex, body mass index, and
presumptive diagnoses were recorded. During the pro›
cedure the operators documented the number of
attempts, the time involved with each, opening and
closing pressure, the volume of cerebrospinal fluid
removed, and the volume of local anaesthetic used.
Immediately after the lumbar puncture, the operator
and the patient evaluated the procedure for ease and
discomfort respectively, with a visual analogue scale
(0›10 cm). If both types of needle were necessary, the
operator scored each needle separately, but the patient
evaluated the procedure as a whole. At 24 hours (or
discharge, if sooner) the patients rated the extent of
headache and backache on separate visual analogue
scales. Nursing staff recorded the length of stay after
lumbar puncture.
Follow up
One week after lumbar puncture, the patients were
telephoned by a single observer who was blinded to
needle allocation. The incidence of both postural
headache and backache were recorded and their sever›
ity graded as mild, moderate, or severe. The duration of
symptoms (hours) and the requirements for analgesia
or medical contact were recorded.
End points
Our primary end point was the incidence of moderate
or severe headache at one week according to needle
type (intention to treat analysis). Our secondary end
points were the incidence of moderate or severe head›
ache at one week by successful needle type, incidence
of headache at 24 hours, incidence of backache at 24
hours and one week, and ease of use by operator. We
undertook additional analyses of the proportion of
patients requiring medical interventions within one
week of lumbar puncture and the proportion
requiring more than one attempt for successful
lumbar puncture. For primary and secondary end
points we calculated the relative risk, absolute risk
reduction, relative risk reduction, and numbers
needed to treat for benefit, with 95% confidence inter›
vals. We compared categorical data by ÷2 tests and
continuous variables by t tests. We calculated the
median and interquartile ranges for the duration of
symptoms, and we compared them with Mann›
Whitney U tests. Correlations were sought with
Pearson’s product moment coefficient.
Fig 1 Atraumatic (top) and standard (bottom) needles for lumbar
puncture
Eligible patients (n=116)
Not randomised (n=15)
Consent refused (n=8)
Incomplete training for
senior house officers (n=7)
Standard needles
allocated (n=49)
Did not receive allocated
intervention (n=1)
Followed up (n=48)
Incidence of headache at
one week
Withdrawn as lost to
follow up (n=1)
Completed trial (n=48)
Atraumatic needles
allocated (n=50)
Did not receive allocated
intervention (n=1)
Followed up (n=49)
Incidence of headache at
one week
Withdrawn as lost to
follow up (n=1)
Completed trial (n=49)
Randomisation
Fig 2 Flow of participants through trial
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Results
Patients’ characteristics
We randomised 101 of 116 eligible patients during the
study period (fig 2), 99 of whom completed the follow
up. Presumptive neurological diagnoses being investi›
gated were multiple sclerosis (73 patients), peripheral
polyneuropathy (4), chronic fatigue (2), motor neurone
disease (2), myelopathy (2), and other cases of
neurological disorders (11). Three patients had
headache disorders at entry to the trial, and three other
patients gave an incidental history of chronic
headache, which was not the reason for investigation.
Patients’ characteristics and procedural measure›
ments at baseline were identical except for higher body
mass index in the standard needle group. Table 1
shows the baseline details.
Two procedures were abandoned and were
therefore excluded from the analyses; one was
abandoned after six attempts (four with atraumatic
needles and two with standard needles) and the second
after four prolonged attempts with the standard
needle. We therefore had complete data for 97 patients
(49 allocated to atraumatic needles and 48 allocated to
standard needles). Lumbar puncture was unsuccessful
after four attempts with the atraumatic needle in eight
patients. All patients subsequently underwent success›
ful lumbar puncture after one attempt with the stand›
ard needle (table 2).
The severity of headache did not differ between the
groups at 24 hours (table 3). The incidence of moder›
ate or severe headache was reduced significantly by
atraumatic needles both by intention to treat analysis
and successful needle analysis (table 4). The incidence
of headache did not correlate with the patient’s age,
sex, or body mass index. The headache at one week in
three patients with major prior headache was severe in
one and absent in two (all randomised to standard
needles). Benefit was maintained irrespective of body
mass index, although smaller numbers were reflected
in wider confidence intervals and loss of significance:
relative risk reduction 46% ( − 3% to 96%), 48% ( − 22%
to 118%), and 56% ( − 31% to 111%) in patients with a
body mass index of less than 25, 25 or more but less
than 29, and 29 or more respectively.
Ease of use
Operators found the atraumatic needle more difficult
to use than the standard needle, although the duration
of the procedure did not differ between the two
needles. Ease of procedure correlated with body mass
index (r = 0.23). Atraumatic needles were associated
with a non›significant increase in the risk of more than
one attempt at lumbar puncture being required (table
4). This risk was related to body mass index: relative
risk of multiple attempts with atraumatic needles was
Table 1 Baseline characteristics of patients randomised to
lumbar puncture with atraumatic or standard needles. Values are
means (SDs) unless stated otherwise
Needle type
P value
Atraumatic
(n=49)
Standard
(n=48)
Age (years) 39.6 (11.5) 40.0 (10.6) 0.85
No of females 32 37
0.20
No of males 17 11
Body mass index 24.3 (4.6) 26.5 (5.2) 0.03
Opening pressure* 16 (4) 17 (5) 0.27
Closing pressure* 14 (4) 15 (4) 0.38
Volume of cerebrospinal fluid (ml) 5.0 (0.8) 4.9 (0.6) 0.37
Volume of local anaesthetic used (ml) 5.7 (9.5) 4.6 (1.5) 0.40
*Pressure=cm cerebrospinal fluid.
Table 2 Operator findings with atraumatic and standard needles
for lumbar puncture
Needle type
P valueAtraumatic Standard
Ease of use (cm) 3.75 2.19 0.003
Procedure time (sec) 219 166 0.24
No of attempts*:
1 31 37
0.04
2 9 10
3 1 0
4 8 1
*Analysed by overall ÷2 test.
Table 4 Primary and secondary end points. Values are numbers of patients unless stated otherwise
End point
Needle type
Relative risk (95% CI)
% Absolute risk
reduction (95% CI)
% Relative risk
reduction (95% CI)
Number needed
to treat (95% CI)Standard Atraumatic
Headache* 26/48 14/49 0.53 (0.15 to 0.78) 26 (6 to 45) 47 (11 to 83) 4 (2 to 17)
Headache (successful needle) 28/56 12/41 0.59 (0.18 to 0.97) 21% (1 to 41) 42 (2 to 81) 5 (3 to 111)
Medical intervention (successful needle) 25/56 10/41 0.55 (0.16 to 0.97) 20 (1 to 40) 45 (2 to 89) 5 (3 to 110)
Repeat lumbar puncture* 11/48 18/49 1.60 (0.80 to 4.75) −14 (−32 to 4) −60 (−247 to 19) −7 (−3 to 23)
Negative numbers indicate detrimental effect of atraumatic needles, positive numbers indicate benefit.
*Intention to treat analysis.
Table 3 Symptoms in patients undergoing lumbar puncture with
atraumatic or standard needles. Values are numbers of patients
unless stated otherwise
Needle type
P valueAtraumatic Standard
Mean (SD) procedure (cm)* 2.7 (2.2) 2.3 (2.2) 0.45
Severity of headache
Mean (SD) at 24 hours (cm)* 0.93 (1.6) 1.5 (2.2) 0.11
At 1 week:
None 28 17
Mild 7 5
Moderate 7 8
Severe 7 18
Median duration (hours)
(interquartile range)
96 (48›144) 120 (72›144) 0.83
Severity of backache
Median (SD) at 24 hours (cm)* 2.3 (2.4) 2.6 (2.4) 0.56
At 1 week:
None 21 17
Mild 18 18
Moderate 6 10
Severe 4 3
Median duration (hours)
(interquartile range)
72 (48›168) 72 (48›168) 0.86
*Results on visual analogue scale.
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non›significantly reduced by 45% (32% reduction to
122% increase) in patients with a body mass index of
less than 25 and significantly increased by 277% (118%
to 436%) in those with a body mass index of 25 or
more. In logistic regression there was a significant
interaction between needle type and body mass index
regarding the need for multiple attempts at lumbar
puncture; neither factor individually was predictive.
Other endpoints
Discomfort during the procedure was graded equally
by patients in both groups. Discharge was not delayed
by symptoms in any patient. Incidence and severity of
backache did not differ between groups at 24 hours or
one week.
The eight patients in whom lumbar puncture was
unsuccessful with atraumatic needles had a higher
body mass index, were younger, found the procedure
more uncomfortable, and described more severe back›
ache at 24 hours than those in whom first lumbar
punctures were successful.
Patients undergoing lumbar puncture with the
standard needle required more medical advice, analge›
sia, and intervention in the week after lumbar
puncture, including two hospital admissions, than
those undergoing the procedure with an atraumatic
needle (table 5). Overall need for medical interventions
was reduced by successful use of the atraumatic needle
(table 4), although the numbers of patients needing
medical contact other than for analgesics were too
small to permit definitive conclusions.
Discussion
Our study confirms a reduced incidence of moderate to
severe headache after diagnostic lumbar puncture with
atraumatic needles in a patient group typical of
neurological practice. We found a higher incidence of
dural puncture headache than some reports—for
example, 25% with moderate to severe headache over
seven days after lumbar puncture with standard 20
gauge needles compared with 16% after lumbar
puncture with atraumatic needles in similar neurological
populations.2 3 Others have reported incidences as high
as 54%, comparable to our results.10 Operator experi›
ence may be a factor, with specifically trained staff or
experienced neurologists in previous studies contrasting
with our less experienced operators, who are typical of
those likely to perform lumbar puncture in UK
hospitals.2 3 Our patients were also younger than those
in some series, and younger age has been associated
with a higher incidence of dural puncture headache.2 11
Point estimates of the number needed to treat for
benefit indicate that one moderate to severe headache
is avoided for every four patients tapped with
atraumatic rather than standard needles: this was at the
potential expense of one additional patient requiring
more than one lumbar puncture attempt for every
seven patients treated. Taking into account the higher
failure rate with atraumatic needles in “successful nee›
dle” rather than intention to treat analysis, the absolute
benefit in terms of headaches and subsequent medical
interventions avoided persisted, with a number needed
to treat of 5 for each end point, but much wider confi›
dence intervals. Reducing the failure rate in practice is
therefore crucial if patients are to benefit from lumbar
punctures with atraumatic needles. The failure rate in
our study (16%) was high, consistent with operators’
grading of atraumatic needles as significantly more dif›
ficult to use than standard needles, notably so in
patients with a high body mass index. The number
needed to treat for benefit would be greater if baseline
incidence was closer to rates suggested in the literature.
On the basis of these data it would be appropriate
to introduce atraumatic needles into standard neuro›
logical practice for diagnostic lumbar puncture,
provided that failure rates are reviewed. Standard
needles will continue to be required, particularly in
patients with a high body mass index, in whom failure
was most often observed. Standard needles will also
continue to be used for therapeutic lumbar punctures
for idiopathic intracranial hypertension or hydro›
cephalus. If these results are borne out in practice, the
sevenfold higher cost of atraumatic needles compared
with standard needles (£5.30 versus £0.78 at local
health board prices) should be offset by the reduced
need for medical intervention.
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Table 5 Medical intervention according to needle type after
successful lumbar puncture
Needle type
Atraumatic
(n=41)
Standard
(n=56)
Telephoned doctor or hospital 0 3
Seen by doctor 2 5
Admitted to hospital 0 2
Analgesia for headache 14 30
What is already known on this topic
The incidence of dural puncture headache can be reduced by using
atraumatic needles for spinal anaesthesia or myelography
A reduction in the incidence of headache has also been shown in two
studies of diagnostic lumbar puncture, but confounding factors such as
differing needle calibres have impeded ascertainment of the magnitude
of benefit, and there are no data on ease of use
What this study adds
A reduced incidence of headache with atraumatic needles was
confirmed: one moderate to severe headache was avoided for every
four patients undergoing lumbar puncture
The need for medical interventions was also reduced with atraumatic
needles: one intervention was avoided for every three patients
undergoing lumbar puncture
Atraumatic needles had a higher failure rate than standard needles
owing to a greater failure rate in patients with a high body mass index;
one additional patient needed more than one attempt for every seven
undergoing lumbar puncture
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Reliability of Snellen charts for testing visual acuity for
driving: prospective study and postal questionnaire
Zanna Currie, Archana Bhan, Irene Pepper
Abstract
Objectives To assess the ability of patients with
binocular 6/9 or 6/12 vision on the Snellen chart
(Snellen acuity) to read a number plate at 20.5 m (the
required standard for driving) and to determine how
health professionals advise such patients about
driving.
Design Prospective study of patients and postal
questionnaire to healthcare professionals.
Subjects 50 patients with 6/9 vision and 50 with 6/12
vision and 100 general practitioners, 100 optometrists
or opticians, and 100 ophthalmologists.
Setting Ophthalmology outpatient clinics in Sheffield.
Main outcome measures Ability to read a number
plate at 20.5 m and health professionals’ advice about
driving on the basis of visual acuity.
Results 26% of patients with 6/9 vision failed the
number plate test, and 34% with 6/12 vision passed it.
Of the general practitioners advising patients with 6/9
vision, 76% said the patients could drive, 13% said
they should not drive, and 11% were unsure. Of the
general practitioners advising patients with 6/12
vision, 21% said the patients could drive, 54% said
they should not drive, and 25% were unsure. The level
of acuity at which optometrists, opticians, and
ophthalmologists would advise drivers against driving
ranged from 6/9 − 2 (ability to read all except two
letters on the 6/9 line of the Snellen chart) to less
than 6/18.
Conclusions Snellen acuity is a poor predictor of an
individual’s ability to meet the required visual
standard for driving. Patients with 6/9 vision or less
should be warned that they may fail to meet this
standard, but those with 6/12 vision should not be
assumed to be below the standard.
Introduction
Drivers must ensure that their vision is good enough to
drive, but people commonly seek the advice of health›
care professionals on this matter. The legal standard
required for driving a private car or motorbike (group
1 entitlement) is to be able to read a number plate at
20.5 m. Guidelines issued by the Driver and Vehicle
Licensing Authority suggest that this corresponds to
between 6/9 and 6/12 vision on the Snellen chart
(Snellen acuity),1 and the guidelines of the Royal
College of Ophthalmologists equate this to about 6/10
vision. However, 6/10 does not exist on standard Snel›
len charts, and professionals might be led to assume
that all those with 6/9 vision meet the required stand›
ard and that those with 6/12 do not.
We aimed to determine what percentage of patients
with 6/9 and of those with 6/12 vision could pass a
number plate test. We then assessed by postal question›
naire the advice given by healthcare professionals.
Participants and methods
Participants
Fifty patients with binocular 6/9 vision and 50 with
6/12 vision were recruited prospectively from ophthal›
mology clinics. Their ability to read a number plate was
tested out of doors at a distance of 20.5 m. Snellen acu›
ity was measured uniocularly and binocularly. We
included patients if they could see the full line on the
Snellen chart binocularly and no more than two letters
on the line below. The patients were given two attempts
at reading a standard front number plate (registration
number F758 EKY). Some numbers and letter›number
combinations are harder to see than others.2 The
number plate we chose represented a moderately diffi›
cult combination. All tests took place between 9 am
and 3 pm during good weather. The patients wore their
usual glasses, but the accuracy of the refraction of the
lenses was not tested. We did not assess visual fields or
driving status.
Questionnaires
Questionnaires were sent by post to 100 ophthalmolo›
gists throughout Great Britain and 100 optometrists or
opticians in South Yorkshire (boxes). A modified ques›
tionnaire went to 100 general practitioners in South
Yorkshire.
Results
Number plate test
The 6/9 and 6/12 vision groups each comprised 21
men and 29 women, with a mean age of 78 (range 43
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